- $32.60m
- -$16.45m
- $11.00m
Annual cashflow statement for Bioatla, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -35.9 | -95.4 | -106 | -123 | -69.8 |
| Depreciation | |||||
| Non-Cash Items | 1.87 | 24.4 | 14.6 | 13.5 | 8.11 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.36 | 7.42 | 0.287 | 4.68 | -11.2 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -36.3 | -62.2 | -90.4 | -104 | -71.9 |
| Capital Expenditures | -0.59 | -0.924 | -0.268 | -0.098 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.003 | 0 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.59 | -0.924 | -0.265 | -0.098 | 0 |
| Financing Cash Flow Items | 200 | -1.91 | -0.758 | -0.259 | -0.046 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 272 | 69.5 | 61.2 | 0.077 | 9.51 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 235 | 6.37 | -29.5 | -104 | -62.4 |